Clinical efficacy and safety of lornoxicam used in patient-controlled analgesia for renal transplatation
- VernacularTitle:氯诺昔康用于肾移植患者术后镇痛的疗效和安全性的临床观察
- Author:
Jin GAO
- Publication Type:Journal Article
- Keywords:
Lornoxicam;
Postoperative analgesia;
Patient-controlled analgesia;
Renal transplatation
- From:
Journal of Chongqing Medical University
2007;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
0bjective:To compared the efficacy and safety of lornoxicam combined with tramadol used in patient-controlled analgesia (PCA) in patients undergoing renal transplatation. Methods:60 patients renal transplatation were randomly divided into Buprenorphine combined with tramadol group(I group) and lornoxicam combined with tramadol group(Ⅱ group). The PCA pump was started according to the need of patients.The efficacy was evaluated by both PAR(pain relief) and TOTPAR(total pain relief),coagulation、transplatation renal survival rate and adverse reactions were also observed.Results:No significant statistical difference in both PAR and TOTPAR as well as renal function were observed between the 2groups,but lornoxicam has less adverse effects.Conclusion:The analgesia effect of Ⅱ group used in PCA for renal transplatation comparable to that of I group but Ⅱ group with less adverse effects.
